Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Aimmune, GameStop: 5 Big Stock Gainers for Monday
By Rob Lenihan
Aug 31, 2020 4:31 PM EDT
PRESS RELEASES
Ionis Appoints Eugene Schneider, M.D., As Executive Vice President And Chief Clinical Development Officer
By PR Newswire
Jan 7, 2021 5:30 PM EST
PRESS RELEASES
Stanley T. Crooke, Ph.D., M.D, To Retire From Ionis To Focus On His Scientific Interests And N-Lorem Foundation
By PR Newswire
Dec 17, 2020 6:30 PM EST
PRESS RELEASES
Ionis Highlights Achievements, Commercial Strategy And Technology Advancements At Investor Day
By PR Newswire
Dec 8, 2020 9:15 PM EST
PRESS RELEASES
Ionis To Participate In Virtual Fireside Chat At BMO 2020 Growth And ESG Conference
By PR Newswire
Dec 2, 2020 7:05 AM EST
PRESS RELEASES
Ionis Announces Initiation Of The Global Phase 3 BALANCE Study For AKCEA-APOCIII-LRX In Patients With Familial Chylomicronemia Syndrome
By PR Newswire
Dec 1, 2020 5:10 PM EST
PRESS RELEASES
Ionis Announces AstraZeneca's Initiation Of The Phase 2b Clinical Study Of Its Antisense Medicine Targeting PCSK9 To Lower LDL-cholesterol
By PR Newswire
Nov 30, 2020 5:15 PM EST
PRESS RELEASES
Ionis Announces Third Investigational Antisense Medicine To Treat Nonalcoholic Steatohepatitis (NASH) Enters Development
By PR Newswire
Nov 23, 2020 5:15 PM EST
PRESS RELEASES
Promising New Data For Ionis' Antisense Medicine Targeting PCSK9 Presented At American Heart Association (AHA) Scientific Sessions 2020
By PR Newswire
Nov 13, 2020 7:05 AM EST
PRESS RELEASES
Ionis' Pioneering Antisense Technology To Be Featured In Multiple Presentations At American Heart Association (AHA) Scientific Sessions 2020
By PR Newswire
Nov 12, 2020 7:05 AM EST
PRESS RELEASES
Ionis' Antisense Technology To Be Featured During Virtual RNA At The Bench And Bedside II Conference
By PR Newswire
Nov 10, 2020 7:05 AM EST
PRESS RELEASES
Ionis To Present At Upcoming Virtual Investor Conferences
By PR Newswire
Nov 9, 2020 7:05 AM EST
PRESS RELEASES
Ionis And Akcea Announce That Pfizer Has Initiated A Phase 2b Clinical Study Of Vupanorsen (AKCEA-ANGPTL3-LRx)
By PR Newswire
Nov 3, 2020 6:00 PM EST
PRESS RELEASES
Ionis And Akcea Win Prestigious Prix Galien Award For TEGSEDI® (inotersen) As Best Biotechnology Product
By PR Newswire
Oct 30, 2020 7:00 AM EDT
PRESS RELEASES
Ionis' Third Novel Antisense Medicine For ALS, Its First Designed To Treat A Broad ALS Population, Begins Clinical Trial
By PR Newswire
Oct 22, 2020 7:05 AM EDT
PRESS RELEASES
Ionis To Hold Third Quarter 2020 Financial Results Webcast
By PR Newswire
Oct 21, 2020 7:05 AM EDT
PRESS RELEASES
Ionis Antisense Medicine Being Evaluated In An Investigator-initiated Clinical Study Of COVID-19 Patients In Brazil
By PR Newswire
Oct 15, 2020 7:05 AM EDT
PRESS RELEASES
Ionis' Inhaled Antisense Medicine Demonstrates Potential As A Novel Treatment For Cystic Fibrosis
By PR Newswire
Oct 13, 2020 7:05 AM EDT
PRESS RELEASES
Ionis Pharmaceuticals Completes Acquisition Of Akcea Therapeutics
By PR Newswire
Oct 12, 2020 9:00 AM EDT
PRESS RELEASES
Ionis Chief Scientific Officer Frank Bennett Receives Lifetime Achievement Award From Oligonucleotide Therapeutics Society
By PR Newswire
Oct 1, 2020 4:05 PM EDT
PRESS RELEASES
(AKCA) Alert: Johnson Fistel Investigates Proposed Sale Of Akcea Therapeutics; Is $18.15 A Fair Price?
By PR Newswire
Sep 1, 2020 5:34 AM EDT
PRESS RELEASES
SHAREHOLDER ALERT: WeissLaw LLP Investigates Akcea Therapeutics, Inc.
By PR Newswire
Aug 31, 2020 8:10 PM EDT
INVESTING
Aimmune, GameStop: 5 Big Stock Gainers for Monday
By Rob Lenihan
Aug 31, 2020 4:31 PM EDT
PRESS RELEASES
Ionis Pharmaceuticals To Hold Second Quarter 2020 Financial Results Webcast
By PR Newswire
Jul 22, 2020 7:05 AM EDT
PRESS RELEASES
Ionis Pharmaceuticals To Present At Upcoming Virtual Investor Conferences
By PR Newswire
Jun 5, 2020 7:05 AM EDT
